How many insider trades does FilingIQ track for PASG?

FilingIQ tracks 124 Form 4 insider transactions for PASG (Passage BIO, Inc.), covering filings from Feb 28, 2020 onwards. 2 of those were filed in the last 90 days.

Are PASG insiders net buyers or net sellers?

Across the full Form 4 history for PASG, 44 transactions (35%) were open-market purchases and 43 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does PASG insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is PASG in?

Passage BIO, Inc. (PASG) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $22.55M.

PASG insider trading

NasdaqCM Healthcare

Passage BIO, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

124

Last 90 days

Buys / sells

35% / 35%

Market cap

$22.55M

About Passage BIO, Inc.

Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; and PBKR03, for the treatment of Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other programs for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. Passage Bio, Inc. was incorporated in 2017 and is based in Philadelphia, Pennsylvania.

Company website: www.passagebio.com

PASG insider activity at a glance

FilingIQ has scored 124 insider transactions for PASG since Feb 28, 2020. The most recent filing in our index is dated Mar 16, 2026.

Across the full history, 44 open-market purchases and 43 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on PASG insider trades is 52.1/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live PASG trades on FilingIQ Raw filings on SEC EDGAR

Latest PASG Form 4 filings

Chou William PRESIDENT AND CEO

S Jan 8, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Top insiders trading PASG

Chou William

5 trades · score 72.0

Borthwick Kathleen

5 trades · score 69.0

Frequently asked

How many insider trades does FilingIQ track for PASG?: FilingIQ tracks 124 Form 4 insider transactions for PASG (Passage BIO, Inc.), covering filings from Feb 28, 2020 onwards. 2 of those were filed in the last 90 days.
Are PASG insiders net buyers or net sellers?: Across the full Form 4 history for PASG, 44 transactions (35%) were open-market purchases and 43 (35%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does PASG insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is PASG in?: Passage BIO, Inc. (PASG) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $22.55M.

Methodology & sources

Every PASG insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.